Angiotensin-converting enzyme inhibitors (ACE inhibitors)
Pro Research Analysisby 
Searched over 200M research papers
Mechanism of Action and Therapeutic Uses of ACE Inhibitors
Angiotensin-converting enzyme (ACE) inhibitors are a class of drugs that lower blood pressure by blocking the conversion of angiotensin I to angiotensin II, a substance that narrows blood vessels and increases blood pressure. By inhibiting ACE, these drugs also increase levels of bradykinin, a peptide that helps relax blood vessels, further contributing to blood pressure reduction and improved heart function. ACE inhibitors are widely used to treat hypertension, heart failure, and kidney diseases, and they can also reduce symptoms in patients with heart failure that is resistant to other treatments like digitalis glycosides and diuretics Antonaccio2015Zheng2022Piepho2000.
Structural Diversity and Pharmacokinetics of ACE Inhibitors
All ACE inhibitors share a basic structure but differ in their functional (binding) groups, such as carboxyl, sulfhydryl, or phosphinyl. These differences affect their pharmacokinetics, potency, and safety profiles. For example, captopril and lisinopril are not prodrugs and do not require activation in the liver, while most other ACE inhibitors do. The elimination of these drugs is mainly through the kidneys, except for lisinopril, which does not require hepatic metabolism. Differences in lipophilicity and tissue ACE inhibition also exist among the various drugs in this class, influencing their clinical use and dosing schedules .
Adverse Effects and Safety Concerns of ACE Inhibitors
While ACE inhibitors are generally well tolerated, they can cause side effects such as low blood pressure, cough, hyperkalemia (high potassium levels), and impaired kidney function. A notable and potentially serious side effect is angioedema, which is swelling of the skin and mucous membranes, most commonly affecting the face, lips, tongue, and sometimes the airways. This reaction is due to the accumulation of bradykinin, which is normally broken down by ACE. Angioedema is rare but can be life-threatening if it affects the airways. Cough and angioedema are considered class effects, and switching to another ACE inhibitor is not recommended if these occur Zheng2022Papapostolou2024Bezalel2015.
Advances in ACE Inhibitor Design and Selectivity
Recent research has focused on improving the selectivity and safety of ACE inhibitors by targeting specific structural domains of the enzyme. High-resolution structural studies and computational modeling have provided insights into how these drugs bind to the enzyme, enabling the design of more selective and potent inhibitors with fewer side effects. These advances may lead to next-generation ACE inhibitors with improved efficacy and safety profiles Zheng2022Acharya2024Caballero2020.
Natural Sources and Novel ACE Inhibitors
There is growing interest in finding natural ACE inhibitors from marine organisms and plants as alternatives to synthetic drugs, which can have significant side effects. Many plant species and marine-derived compounds have shown ACE-inhibitory activity and may offer additional health benefits, such as antioxidant and anti-inflammatory effects. These natural compounds are being explored for their potential to prevent and treat hypertension and diabetes-related complications with fewer adverse effects Wijesekara2010Chakraborty2021.
Conclusion
ACE inhibitors are essential medications for managing high blood pressure, heart failure, and kidney diseases. They work by blocking the formation of angiotensin II and increasing bradykinin levels, leading to blood vessel relaxation and reduced blood pressure. While effective, they can cause side effects like cough and angioedema, and ongoing research aims to develop safer and more selective drugs. Natural ACE inhibitors from plants and marine sources are also being investigated as promising alternatives for future therapies.
Sources and full results
Most relevant research papers on this topic
Overview of the angiotensin-converting-enzyme inhibitors.
ACE inhibitors play a crucial role in the renin-angiotensin system, with differences in potency, affinity for ACE, pharmacokinetics, and toxicity affecting their pharmacokinetic and safety profiles.
DOI